Related Experiment Video
Updated: Mar 17, 2026
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A
Zhen-Yu Li1, Ying-Li Dong2, Yun Feng1
1Department of General Surgery, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang 471009, Henan, China.
Aims:
Recently, the relationship between telomerase reverse transcriptase (TERT) polymorphisms and breast cancer risk has been investigated in several publications. However, the results were inconclusive. In this study, we examined the association between TERT polymorphisms and breast cancer risk by meta-analysis.
Materials And Methods:
The PubMed, Cochrane Library, and EMBASE databases were searched independently by two investigators to retrieve relevant studies published to March 21, 2015. The strength of the association was calculated with the odds ratio (OR) and 95% confidence interval (CI). All statistical tests were used by the RevMan 5.1 software (Nordic Cochrane Center, Copenhagen, Denmark).
Results:
We observed a statistically significant association between rs2736109 polymorphism and breast cancer risk (OR = 1.13; 95% CI: 1.00-1.28; P = 0.04). In addition, rs2736109 polymorphism was associated with breast cancer risk in Caucasian population (OR = 1.18; 95% CI: 1.00-1.38; P = 0.04). We also found rs2853669 and rs2736098 polymorphisms were significantly associated with breast cancer risk (OR = 0.76; 95% CI: 0.63-0.90; P = 0.002 and OR = 0.79; 95% CI: 0.72-0.87; P < 0.00001), respectively. Furthermore, rs10069690 polymorphism was showed to be associated with breast cancer risk (OR = 1.16; 95% CI: 1.11-1.22; P < 0.00001). In the subgroup analysis, this polymorphism might be associated with estrogen receptor-negative breast cancer risk (OR = 1.16; 95% CI: 1.12-1.21; P < 0.00001) and breast cancer risk in Caucasian population (OR = 1.18; 95% CI: 1.14-1.23; P < 0.00001). One single nucleotide polymorphism, rs2735940, was not significantly associated with breast cancer risk (OR = 0.85; 95% CI: 0.66-1.11; P = 0.24).
Conclusion:
This meta-analysis suggested that TERT rs2736109, rs2853669, rs2736098, and rs10069690 polymorphisms were associated with increased risk of developing breast cancer.
More Related Videos
08:26Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein
Published on: June 12, 2018
06:38Droplet Digital TRAP ddTRAP: Adaptation of the Telomere Repeat Amplification Protocol to Droplet Digital Polymerase Chain Reaction
Published on: May 3, 2019
Related Concept Videos
02:41Telomeres and Telomerase
02:41Telomeres and Telomerase
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
02:15Replicative Cell Senescence
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...